Hexarelin

What it is

Hexarelin (examorelin) is a synthetic six-amino-acid GHRP that produces among the most potent GH release of any GHRP. It was developed in the late 1980s and early 1990s and was studied in clinical trials for GH deficiency diagnosis and short-term treatment of GH-related conditions.

Hexarelin’s defining feature is its potency — it produces large GH spikes — but this potency comes with significant tachyphylaxis (rapid loss of effect with continued use) and the most pronounced cortisol elevation of the major GHRPs. These features have limited its long-term clinical utility.

Mechanism of action

Standard GHRP mechanism through ghrelin receptor activation:

• Very potent GH release — among the largest GH spikes producible with any GHRP
• Significant cortisol elevation — more than other GHRPs at equivalent GH-releasing doses
• Prolactin elevation
• Rapid tachyphylaxis — receptor desensitization with chronic use limits sustained effects, requiring drug holidays or limiting cycle length
• Possible direct cardiovascular effects — research has suggested hexarelin has direct effects on cardiac tissue independent of GH effects, with potentially complex implications

Clinical evidence

Hexarelin has been extensively studied in research settings and in early clinical trials. Pharmacology is well-characterized. Clinical development for chronic use was limited by the tachyphylaxis and cortisol concerns.

Why we don’t prescribe it at The Tide

Several features make hexarelin unsuitable for modern chronic GH-axis protocols:

• Tachyphylaxis: rapid loss of effect means hexarelin cannot be used in extended cycles like other GHRPs. This makes it impractical for the multi-week to multi-month protocols typical in adult GH-axis support.
• Cortisol elevation: the most significant of any GHRP, working against the metabolic and recovery goals that typically motivate GH-axis use
• Cardiovascular effects: the documented cardiac effects raise additional concerns for chronic use, particularly in middle-aged and older adults
• Modern alternatives: ipamorelin provides the GH-releasing benefit without these issues

Hexarelin is older-generation pharmacology that does not have a clear role in modern clinical practice for the indications we work with.

Side effects and contraindications

Significant cortisol elevation, tachyphylaxis with continued use, prolactin effects, possible cardiac effects, and standard GH-axis side effects. Contraindicated in malignancy, pregnancy, pituitary disease, cardiovascular disease, severe obesity, uncontrolled diabetes.